Early Identification of Therapeutic Failure in Nonseminomatous Germ Cell Tumors by Assessing Serum Tumor Marker Decline During Chemotherapy: Still Not Ready for Routine Clinical Use-Reference-Cited by-同舟云学术

Early Identification of Therapeutic Failure in Nonseminomatous Germ Cell Tumors by Assessing Serum Tumor Marker Decline During Chemotherapy: Still Not Ready for Routine Clinical Use

Published:2004-10-01 Issue:19 Volume:22 Page:3842-3845
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Toner Guy C.¹

Affiliation:

1. Peter MacCallum Cancer Center, Melbourne, Australia

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.06.923

Reference26 articles.

1. Ries LAG, Eisner MP, Kosary CL, et al: SEER cancer statistics review, 1975-2001 . Bethesda, MD, National Cancer Institute. http://seer.cancer.gov/csr/1975_2001/

2. Early Predicted Time to Normalization of Tumor Markers Predicts Outcome in Poor-Prognosis Nonseminomatous Germ Cell Tumors

3. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

4. Marker Half-Life Analysis as a Prognostic Tool in Testicular Cancer

5. Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum tumor markers in testicular cancer;Urologic Oncology: Seminars and Original Investigations;2013-01

2. The Contemporary Role of Chemotherapy for Advanced Testis Cancer: A Systematic Review of the Literature;European Urology;2012-06

3. Logarithmic decrease of serum alpha-fetoprotein or human chorionic gonadotropin in response to chemotherapy can distinguish a subgroup with better prognosis among highly malignant intracranial non-germinomatous germ cell tumors;Journal of Neuro-Oncology;2011-02-26

4. Predictive Value of Modeled AUCAFP-hCG, a Dynamic Kinetic Parameter Characterizing Serum Tumor Marker Decline in Patients With Nonseminomatous Germ Cell Tumor;Urology;2010-08

5. The Challenge of Poor-Prognosis Germ Cell Tumors;Urologic Clinics of North America;2007-05